Granutec to sell private-label OTC naproxen in January once Aleve exclusivity expires.
This article was originally published in The Tan Sheet
Executive Summary
GRANUTEC PRIVATE-LABEL OTC NAPROXEN SODIUM is set to be introduced immediately following expiration of Aleve's market exclusivity on Jan. 11, 1997. Granutec's parent company, Novopharm, received tentative ANDA approval, pending expiration of the exclusivity period for OTC naproxen sodium 220 mg tablets and caplets, on August 20.